Portfolio company
Infinimmune
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This biotechnology company develops human-derived antibody therapeutics for pharmaceutical partners and patients with atopic dermatitis and other inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Apogee Therapeutics
This biotechnology company develops monoclonal antibody therapies for patients with inflammatory and immunological diseases, including atopic dermatitis, asthma and chronic obstructive pulmonary disease.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.
Innate Pharma
This biotechnology company develops antibody-based immunotherapies for cancer and inflammatory diseases for patients with unmet medical needs.
Inimmune
The company develops immunotherapies and vaccine components to treat patients with allergies, cancer, infectious diseases and autoimmune conditions.
Bionyra Pharma
Bionyra Pharma develops mono and multispecific antibodies for patients with severe immune-mediated inflammatory diseases, including atopic dermatitis and inflammatory bowel disease.
Bluefin Biomedicine
This biotechnology company develops first-in-class antibody medicines for patients with serious inflammatory and oncologic diseases.
Triveni Bio
This biotechnology company develops antibody-based therapies for patients with immunological and inflammatory disorders using a genetics-informed precision medicine approach.
Clim Bio
This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.
